News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website

 

One Out of Five Adults Worldwide May Have a Pituitary Tumor, New Study Shows (PR Newswire)One out of five adults worldwide may have a non-cancerous tumor of their pituitary gland, and at least one-third of these pituitary tumors may be clinically active and causing significant health problems, according to results of a new study presented today at the 10th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists.- May 04 8:02 AM ET



Website: http://biz.yahoo.com/prnews/010504/nyf015.html

Posted on: 05/04/2001

"Yahoo - One Out of Five Adults Worldwide May Have a Pituitary Tumor, New Study Shows"
Yahoo! Finance Finance Home - Yahoo! - Help
PR Newswire

[ Latest Headlines | Market Overview | News Alerts ]


Related Quotes
^DJI
^IXIC
^SPC
^IIX
^PSE
10818.38
2140.82
1249.87
208.69
757.28
+21.73
-5.38
+1.29
-0.95
-5.48
delayed 20 mins - disclaimer

Friday May 4, 8:02 am Eastern Time

Press Release

SOURCE: Pituitary Network Association

One Out of Five Adults Worldwide May Have a Pituitary Tumor, New Study Shows

One Third of These Mostly Non-Cancerous Tumors May Cause Serious Disorders

SAN ANTONIO, May 4 /PRNewswire/ -- One out of five adults worldwide may have a non-cancerous tumor of their pituitary gland, and at least one-third of these pituitary tumors may be clinically active and causing significant health problems, according to results of a new study presented today at the 10th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists (AACE).

The findings are based on an analysis of 12 published studies on the prevalence of pituitary tumors, conducted by clinicians experienced in the management of pituitary disorders.

"The results confirm that pituitary disorders are more common than previously thought, and suggest that many people are living with an undiagnosed condition that may affect every part of their lives, from appearance and sexual function to their emotional and general health," said Sylvia Asa, MD, PhD, Professor, Department of Laboratory Medicine and Pathology, University of Toronto; Pathologist in Chief, University Health Network and Toronto Medical Laboratories; and Incoming President, Pituitary Network Association (PNA).

For instance, untreated patients with acromegaly, a pituitary disease that results in serious changes in appearance and metabolic complications, have a mortality rate that is two to four times higher than average, a figure comparable to those of diabetes and Parkinson's disease. Patients affected by pituitary disease are also at increased risk for life-threatening conditions such as heart disease and diabetes.

"This study is a wake-up call for anyone who perceives pituitary tumors as rare," said acromegaly patient Robert Knutzen, CEO and Chairman of the Pituitary Network Association, an international non-profit organization dedicated to providing support and information to patients with pituitary disorders and the health care providers who treat them.

Pituitary diseases are usually caused by non-cancerous tumors located on the pituitary gland, a small, bean-shaped gland situated in a bony hollow at the brain's base. This "master gland" is the most important of the endocrine glands because it regulates and controls the secretion of hormones that have a dramatic and broad range of effects on metabolism, growth and development, sexuality and reproductive functions. As a result of these tumors, any one of more than a dozen possible pituitary disorders may occur, such as acromegaly, growth hormone deficiency, hyperprolactinemia or Cushing's syndrome.

Common symptoms of pituitary disorders include irregular menses, sexual dysfunction, infertility, changes in physical appearance and unexplained mood changes. To find more information about pituitary disorders and to assess whether you may be at risk, log on to the Pituitary Network Association Web site (http://www.pituitary.org) to take a comprehensive self-assessment test.

"We encourage individuals who are experiencing symptoms to aggressively seek testing and, if diagnosed, to obtain appropriate treatment from a qualified medical expert, namely an endocrinologist or hormone specialist," said Mr. Knutzen.

The mission of the Pituitary Network Association is to support, pursue, encourage, promote and where possible, fund research on pituitary tumors and related pituitary disorders in a sustained and full-time effort to find cures for these illnesses.

The Pituitary Disease Awareness Campaign is sponsored by the Pituitary Network Association through an unrestricted educational grant from Pharmacia Endocrine Care, a division of Pharmacia Corporation. The company markets DOSTINEX® (cabergoline tablets), indicated for hyperprolactinemia, and GENOTROPIN (R) (somatropin [rDNA origin] for injection), approved for replacement therapy in adults with growth hormone deficiency confirmed with appropriate stimulation tests, for growth failure in children due to growth hormone deficiency, and growth failure in children due to Prader Willi syndrome (with a diagnosis confirmed by genetic testing); other causes of short stature in children should be excluded.

                    MAKE YOUR OPINION COUNT -- Click Here
               http://tbutton.prnewswire.com/prn/11690X78555478

SOURCE: Pituitary Network Association

Email this story - Most-emailed articles - Most-viewed articles


Related News Categories: health care, medical/pharmaceutical

Help


Copyright © 2001 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2001 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Questions or Comments?
"
Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740